Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vilacto Bio
AddedFeb 20, 2024
UpdatedJun 18, 2026
Vilacto Bio

Vilacto Bio

Public

Vilacto Bio Inc., a global biotech firm, innovates novel drugs for inflammatory and skin diseases.

HQ
New York City, NY, US
Founded
2013
Overview
Compare
Employees
Website

Vilacto Bio Inc. is a biotech company dedicated to researching and developing novel drugs aimed at treating inflammatory conditions, diabetic ulcers, psoriasis, vitiligo, and other skin diseases. Founded with a mission to improve patient outcomes worldwide, Vilacto Bio focuses on innovative solutions for skin health and regeneration. Their product line includes specialized formulations designed to soothe, repair, and rejuvenate the skin, leveraging patented technologies to address various dermatological needs.

Notable figures associated with Vilacto Bio include key researchers and industry experts who contribute to its pioneering work in biotechnology. The company has garnered attention for its significant advancements in treating chronic skin conditions and has received investment from stakeholders committed to healthcare innovation. Vilacto Bio's impact is evident in its growing global presence and the positive feedback from patients benefiting from their cutting-edge treatments.

Vilacto Bio - Similar Companies

Soltego logo

Soltego

soltego.com

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

arcutis.com

ResVita Bio logo

ResVita Bio

resvitabio.com

Vetica Labs logo

Vetica Labs

Vlst logo

Vlst

Viscient Bio logo

Viscient Bio

Naked Biome logo

Naked Biome

Vyne Therapeutics logo

Vyne Therapeutics

Outer Biosciences logo

Outer Biosciences

outerbio.com

Haus Bioceuticals logo

Haus Bioceuticals

hausbio.com

Apic Bio logo

Apic Bio

Veracity Selfcare logo

Veracity Selfcare

Amplifica logo

Amplifica

amplificabio.com

Lotus Tissue Repair logo

Lotus Tissue Repair

Solarea Bio logo

Solarea Bio

solareabio.com

Vilacto Bio - Quick Facts

Who are Vilacto Bio's competitors?

Companies similar to Vilacto Bio include Soltego, Arcutis Biotherapeutics, ResVita Bio and Vetica Labs.

When was Vilacto Bio founded?

Vilacto Bio was founded in 2013.

Where is Vilacto Bio's headquarters located?

Vilacto Bio's headquarters is located in New York City, NY, US.

How many employees does Vilacto Bio have?

Vilacto Bio has 7 employees as of Feb 5, 2024.

Vilacto Bio - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Skincare Products
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2844Perfumes, Cosmetics, And Other Toilet Preparations
  • 2800Chemicals And Allied Products
ISIC
  • 2023Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and toilet preparations
Show 34 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325600Soap, Cleaning Compound, and Toilet Preparation Manufacturing
  • 325610Soap and Cleaning Compound Manufacturing
  • 325611Soap and Other Detergent Manufacturing
  • 325620Toilet Preparation Manufacturing
  • 334600Manufacturing and Reproducing Magnetic and Optical Media
  • 513200Software Publishers
  • 330000Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 334610Manufacturing and Reproducing Magnetic and Optical Media
  • 513210Software Publishers
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 1820Reproduction of recorded media
  • 5820Software publishing